BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3094239)

  • 1. Intermediate-filament expression in thyroid gland carcinomas.
    Schröder S; Dockhorn-Dworniczak B; Kastendieck H; Böcker W; Franke WW
    Virchows Arch A Pathol Anat Histopathol; 1986; 409(6):751-66. PubMed ID: 3094239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of intermediate filament proteins in thyroid gland and thyroid tumors.
    Miettinen M; Franssila K; Lehto VP; Paasivuo R; Virtanen I
    Lab Invest; 1984 Mar; 50(3):262-70. PubMed ID: 6199582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytokeratin expression of benign and malignant epithelial thyroid gland tumors. An immunohistologic study of 154 neoplasms using 8 different monoclonal cytokeratin antibodies].
    Schröder S; Wodzynski A; Padberg B
    Pathologe; 1996 Nov; 17(6):425-32. PubMed ID: 9082363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermediate filaments in cytological specimens of thyroid tumors.
    Altmannsberger M; Dralle H; Weber K; Osborn M; Droese M
    Diagn Cytopathol; 1987 Sep; 3(3):210-4. PubMed ID: 3311664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cytokeratins and vimentin in epithelial cells of normal and pathologic thyroid tissue.
    Henzen-Logmans SC; Mullink H; Ramaekers FC; Tadema T; Meijer CJ
    Virchows Arch A Pathol Anat Histopathol; 1987; 410(4):347-54. PubMed ID: 2433835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of intermediate filament proteins in normal and diseased thyroid glands.
    Buley ID; Gatter KC; Heryet A; Mason DY
    J Clin Pathol; 1987 Feb; 40(2):136-42. PubMed ID: 3546391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue polypeptide antigen in thyroid tumours of follicular cell origin: an immunohistochemical re-evaluation for diagnostic purposes.
    Tuccari G; Barresi G
    Histopathology; 1990 Apr; 16(4):377-81. PubMed ID: 2361653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical distribution pattern of intermediate filament proteins in 50 feline neoplasms.
    Martín de las Mulas J; Espinosa de los Monteros A; Carrasco L; van Niel M; Fernández A
    Vet Pathol; 1995 Nov; 32(6):692-701. PubMed ID: 8592805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of epithelial- and neural type of intermediate filament proteins in human lung tumors.
    Ramaekers F; Broers J; Rot MK; Oostendorp T; Wagenaar S; Vooijs P
    Acta Histochem Suppl; 1987; 34():45-56. PubMed ID: 3033739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of intermediate filaments in neuroendocrine tumors.
    Kimura N; Nakazato Y; Nagura H; Sasano N
    Arch Pathol Lab Med; 1990 May; 114(5):506-10. PubMed ID: 2159272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of expression of cytoskeletal proteins in human thyroid gland and thyroid carcinomas.
    Dockhorn-Dworniczak B; Franke WW; Schröder S; Czernobilsky B; Gould VE; Böcker W
    Differentiation; 1987; 35(1):53-71. PubMed ID: 2448179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial markers in thyroid carcinoma: an immunoperoxidase study.
    Wilson NW; Pambakian H; Richardson TC; Stokoe MR; Makin CA; Heyderman E
    Histopathology; 1986 Aug; 10(8):815-29. PubMed ID: 2428725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexpression patterns of vimentin and glial filament protein with cytokeratins in the normal, hyperplastic, and neoplastic breast.
    Gould VE; Koukoulis GK; Jansson DS; Nagle RB; Franke WW; Moll R
    Am J Pathol; 1990 Nov; 137(5):1143-55. PubMed ID: 1700618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of expression of intermediate cytokeratin filaments in the thyroid gland: an immunohistochemical study of simple and stratified epithelial-type cytokeratins.
    Fonseca E; Nesland JM; Höie J; Sobrinho-Simões M
    Virchows Arch; 1997 Mar; 430(3):239-45. PubMed ID: 9099982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of c-erbB-2 oncoprotein in human thyroid tumours.
    Utrilla JC; Martín-Lacave I; San Martín MV; Fernández-Santos JM; Galera-Davidson H
    Histopathology; 1999 Jan; 34(1):60-5. PubMed ID: 9934586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced HBME-1 immunoreactivity of papillary thyroid carcinoma and papillary thyroid carcinoma-related neoplastic lesions with Hürthle cell and/or apocrine-like changes.
    Mai KT; Bokhary R; Yazdi HM; Thomas J; Commons AS
    Histopathology; 2002 Feb; 40(2):133-42. PubMed ID: 11952857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of c-erbB-2 protein in papillary thyroid carcinomas.
    Haugen DR; Akslen LA; Varhaug JE; Lillehaug JR
    Br J Cancer; 1992 Jun; 65(6):832-7. PubMed ID: 1352125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoblastoma expression in thyroid neoplasms.
    Anwar F; Emond MJ; Schmidt RA; Hwang HC; Bronner MP
    Mod Pathol; 2000 May; 13(5):562-9. PubMed ID: 10824929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression of cytokeratin, neurofilament and vimentin in carcinoid tumors.
    Kimura N; Sasano N; Namiki T; Nakazato Y
    Virchows Arch A Pathol Anat Histopathol; 1989; 415(1):69-77. PubMed ID: 2472033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of E-cadherin expression in thyroid neoplasms.
    Naito A; Iwase H; Kuzushima T; Nakamura T; Kobayashi S
    J Surg Oncol; 2001 Mar; 76(3):176-80. PubMed ID: 11276021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.